Objective As evidence of partial aetiological overlap between bipolar affective disorder and schizophrenia is accumulating, it is important to determine whether genes implicated in the aetiology of schizophrenia play a role in bipolar disorder, and vice versa. As the neuregulin 1 (NRG1) gene has been associated with schizophrenia, we set out to investigate whether it is also associated with bipolar affective disorder, using a sample from Scotland, UK.
Objective As evidence of partial aetiological overlap between bipolar affective disorder and schizophrenia is accumulating, it is important to determine whether genes implicated in the aetiology of schizophrenia play a role in bipolar disorder, and vice versa. As the neuregulin 1 (NRG1) gene has been associated with schizophrenia, we set out to investigate whether it is also associated with bipolar affective disorder, using a sample from Scotland, UK.
Methods We tested four single nucleotide polymorphisms (SNPs), SNP8NRG221533 (rs35753505), SNP8NRG241930, SNP8NRG243177 (rs6994992) and SNPNRG222662 (rs4623364) for allelic and haplotypic association with bipolar disorder and the presence of psychotic or mood-incongruent psychotic features.
Results We found nominal allele-wise significant association (P = 0.02) for SNP8NRG221533, with the T allele being overrepresented in cases. This is the opposite allelic association to the original association study where the C allele was associated with schizophrenia. Allele-wise significance increased when we tested for association with the subgroups of bipolar disorder with psychotic features (v 2 = 8.53; P = 0.003; odds ratio = 1.49) and, more specifically, with mood-incongruent psychotic features (v 2 = 7.13; P = 0.008; odds ratio = 1.57). Furthermore, both these subphenotypes were significantly associated with the SNP8NRG221533 (T 
Introduction
Current psychiatric nosology separates bipolar affective disorder and schizophrenia into nonoverlapping categories. However, there is evidence of partial aetiological overlap between them from genetic epidemiology and molecular genetics studies, including linkage analysis and association analysis (Berrettini, 2003; Craddock et al., 2005) . Thus, it is important to determine whether genes implicated in the aetiology of schizophrenia play a role in bipolar disorder (and vice versa).
Neuregulin 1 (NRG1) is a plausible susceptibility gene because of its involvement in neurodevelopment, regulation of glutamate and other neurotransmitter receptor expression and synaptic plasticity (Tosato et al., 2005) . Since then, there have been several confirmatory reports that NRG1 is a susceptibility gene for schizophrenia, as well as negative studies (Tosato et al., 2005) . However, a meta-analysis indicates that the overall data is strongly supportive of a role for NRG1 in susceptibility to schizophrenia . Psychotic (especially mood incongruent) features possibly represent the link between both disorders, as they show familial clustering in bipolar disorder and families with psychotic bipolar disorder show linkage to schizophrenia loci. Park et al. (2004) have shown significant genome-wide linkage of bipolar disorder with psychotic symptoms to 8p21 (lod = 3.46) and suggestive linkage to 8p12, as for several other regions shared with schizophrenia. Earlier to Park et al. (2004) ; Ophoff et al. (2002) had also found the strongest linkage in their bipolar I family sample to be in chromosome 8p. Furthermore, Green et al. (2005) found that the NRG1 core haplotype was associated with bipolar disorder.
In this study, we investigated single-point and haplotypic association of four single nucleotide polymorphisms (SNPs) in the NRG1 gene with bipolar disorder and diagnostic subtypes with psychotic or mood-incongruent psychotic features. The SNPs were chosen as they are among the polymorphisms in the core risk-haplotype for schizophrenia that show the most significant association in Caucasians, as reported in a recent meta-analysis .
Methods
We analysed a sample composed of 213 Bipolar Disorder I cases and 197 controls drawn from Scotland (sample 1), that is, the same geographic region as the population used to replicate the original association report between schizophrenia and NRG (Stefansson et al., 2003) . We also used a second European Caucasian sample of predominant English ancestry (sample 2), consisting of 108 Bipolar Disorder I cases and 101 new controls ascertained in the same way as the Scottish sample. Diagnosis was made following the guidelines of Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Both samples were white Caucasian. Informed written consent was given by all participants. Consensus diagnosis was determined by trained psychologists and psychiatrists based on case-note review and clinical interview using semi-structured diagnostic questionnaires. The total sample (1+2) of 321 cases and 298 controls, has 79% power to detect a heterozygote odds ratio (OR) of 1.5 and a homozygote OR of 2 at the 0.05 level for a risk allele of frequency 0.19. We genotyped four SNPs, from which three are a part of the schizophrenia risk haplotype of Stefansson et al. (2002) , namely SNP8NRG221533 (rs35753505), SNP8NRG241930 and SNP8NRG243177 (rs6994992) (http://www.decode.com/nrg1/markers/) and one additional SNP, SNPNRG222662 (rs4623364). The genotyping was performed for both samples under contract by KBioscience (http://www.kbioscience.co.uk) using a competitive allele specific PCR system. Quality control criteria were that genotypes form three distinct clusters, water controls were negative, the number of callable genotypes were higher than 90% and minor allele frequency was greater than 0.02. In addition, interplate and intraplate duplicate testing of known DNAs was performed. All genotyping was performed sequentially by the same method and blind to status.
For the genotype and allele-wise statistical analysis, we used both w 2 and Fisher's Exact Test to analyse the individual polymorphisms. Allele-wise analysis followed the Mantel-Haensel method. Binary logistic regression performed in SPSS Version 12 (Statistical Package for Social Sciences version 12) (SPSS Inc., Chicago, Illinois, USA), which corrects for subsample differences was used to confirm w 2 results for the combined sample (sample 1+sample 2). All SNPs were in Hardy-Weinberg equilibrium, except for SNP221533 which was out at P = 0.02 for the control group of sample 2. We applied Bonferroni correction for multiple comparisons to all significant results, by multiplying the original P values by a factor of 4. We think this value is a fair one, given that we used three phenotypes that are not independent from each other as they are correlated, and we have also used four SNPs that were in linkage disequilibrium with each other.
GENECOUNTING software (version 1.3, March 2003; Zhao et al., 2002) was used to estimate the haplotype frequencies from the genotype data (with 1000 permutations/simulations). All SNPs were in significant linkage disequilibrium with each other which was assessed with Cramer's V (R 2 ) and Absolute D' tests in genecounting (Table 1) .
Results
An allele-wise w 2 test case-control association analysis in samples 1 and 2 individually revealed no significant positive association between NRG1 and bipolar disorder, although SNP8NRG221533 (also named rs35753505) showed a trend of uncorrected P = 0.09 both in sample 1 (w 2 = 2.91; OR = 1.29) and sample 2 (w 2 = 2.81; OR = 1.40) as a result of an excess of allele T in cases. Combining the two samples in a total of 321 cases and 298 controls gave a significant allele-wise association at uncorrected P = 0.02 (w 2 = 5.32; OR = 1.33; Bonferroni correction: P = 0.08) with the allele T of SNP8N RG221533, frequencies being 64.5 for cases and 58.9% for controls. The other three SNPs showed no trend towards association with bipolar disorder. A binary logistic regression analysis, which corrects for subsample differences, confirmed this result (P = 0.015; w 2 = 5.94; OR = 1.28). Haplotype analysis was not significant either in each sample individually or in both samples combined (data not shown).
We next compared the psychotic group (N = 205; 65% of the patients) against the control individuals in the combined sample. SNP8NRG221533 (w 2 = 8.53; P = 0.003; OR = 1.49; Bonferroni correction: P = 0.012) and SNP8NRG222662 (w 2 = 5.49; P = 0.02; OR = 1.41; Bonferroni correction: P = 0.08) both showed a significant allele-wise association, the latter SNP surviving correction for multiple testing (Table 2) .
From the total group of psychotic bipolar patients (N = 205), we further analysed a subgroup of patients with mood-incongruent psychotic features (N = 110) and compared them against all controls. This group discrimination yielded a higher allele-wise significance than the use of the broad phenotype of bipolar disorder for SNP8NRG221533 (P = 0.0076; w 2 = 7.13; OR = 1.57; Bonferroni correction: P = 0.0023), SNP8NRG222662 (P = 0.014; w 2 = 5.98; OR = 1.56; Bonferroni correction: P = 0.056) and SNP8NRG243177 (P = 0.05; w 2 = 3.7; OR = 1.36; Bonferroni correction: P = 0.2), with the first SNP surviving correction for multiple testing.
Haplotype analyses were also performed with the latter comparisons (psychotic bipolar disorder versus controls and mood-incongruent psychotic bipolars versus controls) ( Table 3 ). The first comparison showed a significant association for the SNP8NRG221533-SNP8NRG241930 haplotype (Alleles: T-G) (w 2 = 11.94; global P = 0.027; specific P = 0.009), as well when SNP8NRG241930 was added forming an extended haplotype: SNP8NRG22153 3-SNPNRG222662-SNP8NRG241930 (Alleles: T-C-G) (w 2 = 19.98; global P = 0.009; specific P = 0.005). Furthermore, the first two-SNP combination (Alleles: T-G) was also more significantly represented in mood-incongruent psychotic bipolars compared with controls (w 2 = 11.88; global P = 0.019; specific P = 0.005).
Discussion
SNP8NRG221533 is the SNP which appears most frequently in schizophrenia-associated haplotypes, including the original core haplotype in the Icelandic and Scottish populations (Stefansson et al., 2003) . It was also the single marker most significantly associated in the original investigation (Stefansson et al., 2002) and furthermore it has shown significant association in follow-up studies (Stefansson et al., 2003; Yang et al., 2003) , including a meta-analysis . Interestingly, our study shows association of this SNP with bipolar disorder but with allele T being in significant excess, instead of the C allele as in haplotypes of the aforementioned schizophrenia association studies. Furthermore, in the bipolar study of Green et al. (2005) , the associated haplotype contained the C allele, although it was not found to be associated individually with the bipolar phenotype.
Moreover, we found stronger association of NRG1 with mood-incongruent psychotic features than with the overall diagnosis of bipolar disorder, which was also a conclusion of the haplotype findings of Green et al. (2005) . In our case, this association was again with allele T of SNP8NRG221 533, allele C of SNP8NRG222662 and allele C of SNP8NRG243177 (also the opposite allele to the one found in the haplotype studies of Green et al., 2003 and Stefansson et al., 2003) . Our haplotype analysis also revealed that this subphenotype was significantly associated with the SNP8NRG221533(T)-SNP8NRG241930(G) haplotype but not with bipolar in general.
Although association with psychosis (haplotypic or with individual markers) had not reached significance in the study of Green et al. (2005) , we found that experiencing psychosis in general (either classified as mood congruent or mood incongruent) was also associated with an excess of allele T of SNP8NRG221533 and of allele C of SNP8 NRG222662 as well as with the SNP8NRG221533(T)-S NP8NRG241930(G) and the SNP8NRG221533(T)-SN P8NRG222662(C)-SNP8NRG241930(G) haplotypes.
Our study supports the finding of Park et al. (2004) that psychotic bipolar disorder shows linkage to the 8p12 region, whereas earlier meta-analyses of bipolar disorder genome scans (e.g. Badner and Gershon, 2002) have not implicated the NRG1 locus. However, the sample size used here is limited compared with previous positive association studies (Stefansson et al., 2002; Stefansson et al., 2003; Green et al., 2005) and, different to those, (i) we have not investigated the full core haplotype in NRG1, but only four SNPs and (ii) we have detected association with the opposite allele in SNP8NRG221533. Therefore, limited comparison between studies is advised.
In conclusion, this study provides increasing evidence that NRG1 may play a role in the development of psychosis in general and not just schizophrenia, thereby supporting a non-Kraepelinian classification of bipolar disorder and schizophrenia. Our data also show that the role of NRG1 may also be important in vulnerability to mood-incongruent features in psychosis. The finding of association between other 'schizophrenia' susceptibility genes and bipolar disorder, such as dysbindin Breen et al., 2006) and disrupted in schizophrenia 1 (Hodgkinson et al., 2004) indicates that there may be several genes that contribute to psychosis susceptibility across the traditional Kraepelinian divide. As our study shows for NRG1, with these and other candidate genes (e.g. DAO, G72, etc.), it is still not clear which alleles within the associated haplotypes are indeed overtransmitted with the disease and further investigation into this is warranted.
